This site is intended for health professionals only

At the heart of general practice since 1960

Resources

An overview of VTE

This guide provides an overview of the signs and symptoms, risk factors, and complications of VTE.

VTE Overview

Managing VTE

  • VTE patient information leaflet - Helping to treat deep vein thrombosis and pulmonary embolism, and helping prevent recurrence
  • Anticoagulant alert card – Providing helpful reminders for patients and vital information for healthcare professionals that treat them

Preventing recurrence





VTE Treatments

This guide provides an overview of the dosing regimens, and clinical pharmacology of NOACs.

Key clinical trials of NOACs

This guide provides an overview of the results from key clinical trials of NOACs in VTE.



ELIQUIS in VTE

To support you with initiating ELIQUIS (apixaban) in your patients with VTE you can use our DVT / PE Prescriber Checklist, available here.

Click here to view ELIQUIS (apixaban) prescribing and adverse event reporting information.

Previous

Abbreviations

ACCP = American College of Chest Physicians AF = Atrial Fibrillation BD = Twice Daily CI = Confidence Interval CPRD = Clinical Practice Research Datalink CrCl = Creatinine Clearance CTEPH Chronic Thromboembolic Pulmonary Hypertension DVT = Deep Vein Thrombosis ESC = European Society of Cardiology HCP = Health Care Professional INR = International Normalised Ratio LMWH = Low Molecular Weight Heparin NHS = National Health Service NICE = National Institute for Health and Care Excellence NOAC = Non-vitamin K antagonist Oral Anticoagulant OAC = Oral Anticoagulant OD = Once Daily PE = Pulmonary Embolism PTS = Post-Thrombotic Syndrome SIGN = Scottish Intercollegiate Guidelines Network SMC = Scottish Medicines Consortium VKA = Vitamin K Antagonist VTE = Venous Thromboembolism

YOU ARE ABOUT TO LEAVE THIS WEBSITE.

×

This link takes you to a third party website (outside of the Bristol-Myers Squibb Group and Pfizer Group). Bristol-Myers Squibb and Pfizer has no control over the content or management of third party websites nor can it be held responsible or liable for such content or management. Please make sure the contents therein are suitable for you as per its intended audience and the applicable laws and regulations. It is recommended that you carefully read the legal notice and cookies and privacy policy of third party websites before accessing these sites.

If you wish to continue, click ‘Continue’, otherwise click ‘Stay on this site’.

Continue Stay on this site

YOU ARE ABOUT TO LEAVE THIS WEBSITE.

×

This link takes you to a third party website (outside of the Bristol-Myers Squibb Group and Pfizer Group). Bristol-Myers Squibb and Pfizer has no control over the content or management of third party websites nor can it be held responsible or liable for such content or management. Please make sure the contents therein are suitable for you as per its intended audience and the applicable laws and regulations. It is recommended that you carefully read the legal notice and cookies and privacy policy of third party websites before accessing these sites.

If you wish to continue, click ‘Continue’, otherwise click ‘Stay on this site’.

Continue Stay on this site

YOU ARE ABOUT TO LEAVE THIS WEBSITE.

×

This link takes you to a third party website (outside of the Bristol-Myers Squibb Group and Pfizer Group). Bristol-Myers Squibb and Pfizer has no control over the content or management of third party websites nor can it be held responsible or liable for such content or management. Please make sure the contents therein are suitable for you as per its intended audience and the applicable laws and regulations. It is recommended that you carefully read the legal notice and cookies and privacy policy of third party websites before accessing these sites.

If you wish to continue, click ‘Continue’, otherwise click ‘Stay on this site’.

Continue Stay on this site

YOU ARE ABOUT TO LEAVE THIS WEBSITE.

×

This link takes you to a third party website (outside of the Bristol-Myers Squibb Group and Pfizer Group). Bristol-Myers Squibb and Pfizer has no control over the content or management of third party websites nor can it be held responsible or liable for such content or management. Please make sure the contents therein are suitable for you as per its intended audience and the applicable laws and regulations. It is recommended that you carefully read the legal notice and cookies and privacy policy of third party websites before accessing these sites.

If you wish to continue, click ‘Continue’, otherwise click ‘Stay on this site’.

Continue Stay on this site

Job code: 432UK1900506-01
Date of preparation: September 2019

BMS  Pfizer stacked Logo